Literature DB >> 11009196

Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy.

P Martinelli1, C Scaglione, R Lodi, S Iotti, B Barbiroli.   

Abstract

Brain and muscle energy metabolism was assessed in vivo in five patients with progressive supranuclear palsy (PSP) using phosphorous magnetic resonance spectroscopy (31P MRS). 31P MRS disclosed a reduced phosphocreatine (PCr) and an increased calculated free adenosine diphosphate (ADP) in the occipital lobes of all patients. In our patients with PSP, inorganic phosphate (Pi) was significantly increased and Mg2+ was reduced. In the gastrocnemius muscle, Pi at rest was increased in four patients, and the three patients who were able to perform an incremental exercise showed a rate of PCr postexercise recovery slower than control subjects. Our findings show that multisystemic deficit of energy metabolism occurs in PSP and suggest that it may play a role in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009196     DOI: 10.1002/1531-8257(200009)15:5<889::aid-mds1020>3.0.co;2-t

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

2.  Effect of altitude on brain intracellular pH and inorganic phosphate levels.

Authors:  Xian-Feng Shi; Paul J Carlson; Tae-Suk Kim; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Seong-Eun Kim; Breanna Glaeser; Kristina Wang; Chun S Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Psychiatry Res       Date:  2014-04-13       Impact factor: 3.222

3.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment.

Authors:  E Hattingen; H Lanfermann; S Menon; T Neumann-Haefelin; R DuMesnil de Rochement; M Stamelou; G U Höglinger; J Magerkurth; U Pilatus
Journal:  MAGMA       Date:  2008-10-15       Impact factor: 2.310

5.  Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons.

Authors:  Myriam Escobar-Khondiker; Matthias Höllerhage; Marie-Paule Muriel; Pierre Champy; Antoine Bach; Christel Depienne; Gesine Respondek; Elizabeth S Yamada; Annie Lannuzel; Takao Yagi; Etienne C Hirsch; Wolfgang H Oertel; Ralf Jacob; Patrick P Michel; Merle Ruberg; Günter U Höglinger
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

6.  Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders.

Authors:  Slawomir Michalak; Jolanta Florczak-Wyspiańska; Joanna Rybacka-Mossakowska; Wojciech Ambrosius; Krystyna Osztynowicz; Aleksandra Baszczuk; Wojciech Kozubski; Ewa Wysocka
Journal:  Oxid Med Cell Longev       Date:  2017-09-10       Impact factor: 6.543

Review 7.  Frontrunner in Translation: Progressive Supranuclear Palsy.

Authors:  Ali Shoeibi; Nahid Olfati; Irene Litvan
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

8.  Energy expenditure, body composition and dietary habits in progressive supranuclear palsy.

Authors:  Marina Picillo; Maria Francesca Tepedino; Maria Claudia Russillo; Filomena Abate; Marta Savastano; Antonio De Simone; Roberto Erro; Maria Teresa Pellecchia; Paolo Barone
Journal:  J Neurol       Date:  2021-10-21       Impact factor: 6.682

9.  CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.

Authors:  Diana Apetauerova; Stephanie A Scala; Robert W Hamill; David K Simon; Subash Pathak; Robin Ruthazer; David G Standaert; Talene A Yacoubian
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.